5OR9
Crystal Structure of BAZ2B bromodomain in complex with 1-methyl-cyclopentapyrazole compound 13
Summary for 5OR9
| Entry DOI | 10.2210/pdb5or9/pdb |
| Related | 5OR8 |
| Descriptor | Bromodomain adjacent to zinc finger domain protein 2B, (2~{S})-1-(4-fluorophenyl)sulfonyl-~{N}-(2-methyl-5,6-dihydro-4~{H}-cyclopenta[c]pyrazol-3-yl)pyrrolidine-2-carboxamide, 1,2-ETHANEDIOL, ... (4 entities in total) |
| Functional Keywords | four helical bundle, transcription |
| Biological source | Homo sapiens (Human) |
| Cellular location | Nucleus : Q9UIF8 |
| Total number of polymer chains | 1 |
| Total formula weight | 14073.17 |
| Authors | Lolli, G.,Vedove, A.D.,Marchand, J.-R.,Caflisch, A. (deposition date: 2017-08-15, release date: 2017-09-13, Last modification date: 2024-01-17) |
| Primary citation | Marchand, J.R.,Dalle Vedove, A.,Lolli, G.,Caflisch, A. Discovery of Inhibitors of Four Bromodomains by Fragment-Anchored Ligand Docking. J Chem Inf Model, 57:2584-2597, 2017 Cited by PubMed Abstract: The high-throughput docking protocol called ALTA-VS (anchor-based library tailoring approach for virtual screening) was developed in 2005 for the efficient in silico screening of large libraries of compounds by preselection of only those molecules that have optimal fragments (anchors) for the protein target. Here we present an updated version of ALTA-VS with a broader range of potential applications. The evaluation of binding energy makes use of a classical force field with implicit solvent in the continuum dielectric approximation. In about 2 days per protein target on a 96-core compute cluster (equipped with Xeon E3-1280 quad core processors at 2.5 GHz), the screening of a library of nearly 77 000 diverse molecules with the updated ALTA-VS protocol has resulted in the identification of 19, 3, 3, and 2 μM inhibitors of the human bromodomains ATAD2, BAZ2B, BRD4(1), and CREBBP, respectively. The success ratio (i.e., number of actives in a competition binding assay in vitro divided by the number of compounds tested) ranges from 8% to 13% in dose-response measurements. The poses predicted by fragment-based docking for the three ligands of the BAZ2B bromodomain were confirmed by protein X-ray crystallography. PubMed: 28862840DOI: 10.1021/acs.jcim.7b00336 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (2 Å) |
Structure validation
Download full validation report
